David Juergen Wustrow

USPTO Granted Patents = 43 (Patent Applications = 9)

CIPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 207(Granted Patents)

Company Filing History:

31 out of 2,538

Warner-lambert Company

Ortho Pharmaceutical Corporation

patents

Years Active: 1991-2009

Loading Chart...

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7517909 - Amino acids with affinity for the α2δ-protein (2009-04-14),

2. 7491835 - Prodrugs of amino acids with affinity for the α2δ-protein (2009-02-17),

3. 7432299 - Method of treatment for sexual dysfunction (2008-10-07),

4. 7381747 - Alpha 2 delta ligands for post-traumatic stress disorder (2008-06-03),

5. 7250433 - Tetrazole and oxadiazolone substituted β-amino acid derivatives (2007-07-31),

6. 7189747 - Method of treating noninflammatory cartilage damage (2007-03-13),

7. 7164034 - Alpha2delta ligands for fibromyalgia and other disorders (2007-01-16),

8. 7138542 - Method of treating tinnitus (2006-11-21),

9. 7122678 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2006-10-17),

10. 7064147 - Amino acids with affinity for the α-2-delta-protein (2006-06-20),

11. 7030267 - Cycloproply β-amino acid derivatives (2006-04-18),

12. 7026505 - Method of treating tinnitus (2006-04-11),

13. 6921835 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2005-07-26),

14. 6809119 - Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases (2004-10-26),

15. 6642398 - Mono-and disubstituted 3-propyl gamma-aminobutyric acids (2003-11-04),

Title: Spotlight on Inventor David Juergen Wustrow

Introduction: David Juergen Wustrow is a prolific inventor based in Ann Arbor, MI, with an impressive portfolio of 43 patents to his name. His groundbreaking work in pharmaceuticals has garnered attention for its potential to revolutionize the treatment of various disorders.

Latest Patents: Wustrow's latest patents include "Amino acids with affinity for the α2δ-protein" and "Prodrugs of amino acids with affinity for the α2δ-protein." These inventions focus on compounds that bind to the alpha-2-delta (α2δ) subunit of a calcium channel, offering promising avenues for the management of psychiatric, pain, and other conditions.

Career Highlights: Throughout his career, Wustrow has made significant contributions while working at reputable companies such as Warner-Lambert Company and Pfizer Corporation. His expertise in pharmacology and drug development has led to the creation of innovative solutions with far-reaching implications.

Collaborations: Wustrow has collaborated closely with noteworthy peers in the industry, including Andrew John Thorpe and Lawrence D Wise. Together, they have explored novel approaches to addressing complex medical challenges and advancing the field of pharmaceutical research.

Conclusion: David Juergen Wustrow's dedication to innovation and his remarkable achievements in the realm of pharmaceuticals underscore his status as a pioneering inventor. His relentless pursuit of scientific excellence continues to inspire progress and holds great promise for the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.